Clinical Trial Update: Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women [Phase 4]

View source ↗

Summary

This entry documents a Phase 4 trial comparing generic zoledronic acid to the original formulation in postmenopausal osteoporosis. Status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)
• Zoledronic acid (generic) (zoledronic acid)

Snippet

Sponsor: Cttq | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: UNKNOWN